New guidance on joint briefing documents for ODAC meetings emphasizes the concept of separate contributions from the sponsor and agency. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
